Self-Perception of Drooling Impact in People with Parkinson's Disease: A Case-Control and Cross-Sectional Study

被引:0
作者
Nascimento, David [1 ,2 ]
Meira, Bruna [3 ]
Garcez, Luis [1 ,4 ]
Abreu, Daisy [5 ]
Outeiro, Tiago F. [6 ,7 ]
Guimaraes, Isabel [1 ,8 ]
Ferreira, Joaquim J. [1 ,9 ]
机构
[1] Univ Lisbon, Fac Med, Lab Clin Pharmacol Therapeut, Ave Prof Egas Moniz, P-1649028 Lisbon, Portugal
[2] Hosp Egas Moniz, Dept Otolaryngol, Swallowing Disorders Unit, Unidade Local Saude Lisboa Ocidental, Lisbon, Portugal
[3] Hosp Egas Moniz, Dept Neurol, Unidade Local Saude Lisboa Ocidental, Lisbon, Portugal
[4] Univ Lisbon, Fac Ciencias, CEAUL Ctr Estatis & Aplicacoes, Lisbon, Portugal
[5] Fac Med, AIDFM Assoc Invest & Desenvolvimento, Lisbon, Portugal
[6] Univ Med Ctr Gottingen, Ctr Biostruct Imaging Neurodegenerat, Dept Expt Neurodegenerat, Gottingen, Germany
[7] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Framlington Pl, Newcastle Upon Tyne, England
[8] Santa Casa Misericordia Lisboa, Alcoitao Hlth Sch Sci, Lisbon, Portugal
[9] CNS Campus Neurol, Torres Vedras, Portugal
关键词
Parkinson's disease; drooling; sialorrhea; MUSCARINIC RECEPTOR SUBTYPES; QUALITY-OF-LIFE; ORAL-HEALTH; PATHOPHYSIOLOGY; IMPAIRMENT; PREVALENCE; SYMPTOMS; MOVEMENT; LEVODOPA; FLOW;
D O I
10.1002/mdc3.70077
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundDrooling, defined as the involuntary loss of saliva from the anterior oral cavity, is potentially problematic for people with Parkinson's disease (PwP). However, there is little research on how PwP perceive the impact of drooling and what factors contribute to it. ObjectivesThe objective was to evaluate the self-perceived impact of drooling in people with and without Parkinson's disease and the contributing clinical factors in PwP. MethodsWe conducted a cross-sectional and case-control study. Participants were clinically examined, and the primary outcome was the Sialorrhea Clinical Scale for Parkinson's disease. Clinical variables were compared between PwP and control subjects using the Mann-Whitney test, correlations between drooling impact and clinical factors in PwP were analyzed using Spearman's test, and predictors were identified using linear regression. ResultsThe study included 101 PwP and 101 sex- and age-matched controls. PwP experienced significantly more severe impact of drooling compared to controls across all domains: diurnal and nocturnal drooling, drooling severity and frequency, social discomfort, speech, and eating impairments. The greater impact of drooling in PwP was significantly associated with drooling severity, disease duration, levodopa equivalent daily dose, clinical global impression of saliva accumulation (CGI-S), chewing, swallowing, speech, oromotor, motor and non-motor impairments. Significant predictors of greater impact of drooling in PwP include drooling severity, higher CGI-S, facial expression, and swallowing impairments. ConclusionsPwP have a significantly greater impact of drooling compared to controls, affecting several domains. Drooling impact and its contributing clinical factors should be investigated in a Parkinson's consultation.
引用
收藏
页数:11
相关论文
共 72 条
[1]   The clinical approach to movement disorders [J].
Abdo, Wilson F. ;
van de Warrenburg, Bart P. C. ;
Burn, David J. ;
Quinn, Niall P. ;
Bloem, Bastiaan R. .
NATURE REVIEWS NEUROLOGY, 2010, 6 (01) :29-37
[2]   Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder [J].
Abrams, Paul ;
Andersson, Karl-Erik ;
Buccafusco, Jerry J. ;
Chapple, Christopher ;
de Groat, William Chet ;
Fryer, Alison D. ;
Kay, Gary ;
Laties, Alan ;
Nathanson, Neil M. ;
Pasricha, Pankaj Jay ;
Wein, Alan J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (05) :565-578
[3]   Orofacial function and oral health in patients with Parkinson's disease [J].
Bakke, Merete ;
Larsen, Stine L. ;
Lautrup, Caroline ;
Karlsborg, Merete .
EUROPEAN JOURNAL OF ORAL SCIENCES, 2011, 119 (01) :27-32
[4]   Orofacial function and temporomandibular disorders in Parkinson's Disease: a case-controlled study [J].
Baram, Sara ;
Thomsen, Carsten Eckhart ;
Ozhayat, Esben Boeskov ;
Karlsborg, Merete ;
Bakke, Merete .
BMC ORAL HEALTH, 2023, 23 (01)
[5]   Self-assessment of oral health, dental health care and oral health-related quality of life among Parkinson's disease patients [J].
Barbe, Anna Greta ;
Bock, Nadine ;
Derman, Sonja Henny Maria ;
Felsch, Moritz ;
Timmermann, Lars ;
Noack, Michael Johannes .
GERODONTOLOGY, 2017, 34 (01) :135-143
[6]   Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation [J].
Bejjani, BP ;
Gervais, D ;
Arnulf, I ;
Papadopoulos, S ;
Demeret, S ;
Bonnet, AM ;
Cornu, P ;
Damier, P ;
Agid, Y .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 68 (05) :595-600
[7]   Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson's disease [J].
Bergmans, Bruno ;
Clark, Veronica ;
Isaacson, Stuart H. ;
Baumer, Tobias .
CLINICAL PARKINSONISM & RELATED DISORDERS, 2023, 9
[8]   Debilitating consequences of drooling [J].
Bloem, B. R. ;
Kalf, J. G. ;
van de Kerkhof, P. C. M. ;
Zwarts, M. J. .
JOURNAL OF NEUROLOGY, 2009, 256 (08) :1382-1383
[9]   Contribution of Axial Motor Impairment to Physical Inactivity in Parkinson Disease [J].
Bryant, Mon S. ;
Hou, Jyhgong Gabriel ;
Collins, Robert L. ;
Protas, Elizabeth J. .
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2016, 95 (05) :348-354
[10]   Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity [J].
Bymaster, FP ;
Carter, PA ;
Yamada, M ;
Gomeza, J ;
Wess, J ;
Hamilton, SE ;
Nathanson, NM ;
McKinzie, DL ;
Felder, CC .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 17 (07) :1403-1410